Selected article for: "different severity and disease severity"

Author: van Rijn, Anneloes L.; van Boheemen, Sander; Sidorov, Igor; Carbo, Ellen C.; Pappas, Nikos; Mei, Hailiang; Feltkamp, Mariet; Aanerud, Marianne; Bakke, Per; Claas, Eric C. J.; Eagan, Tomas M.; Hiemstra, Pieter S.; Kroes, Aloys C. M.; de Vries, Jutte J. C.
Title: The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease
  • Document date: 2019_10_24
  • ID: 0rupk21u_41
    Snippet: The following markers were tested for potential associations with clinical severity of exacerbation (exacerbation severity, self-reported exacerbation severity), length of exacerbation and a decrease/increase in FEV 1 (control visit compared to baseline): mNGS pathogen positive versus negative exacerbation (qPCR targets), the number of normalized reads (log, cutoff of �5normalized reads) for the different target viruses (species level). No corr.....
    Document: The following markers were tested for potential associations with clinical severity of exacerbation (exacerbation severity, self-reported exacerbation severity), length of exacerbation and a decrease/increase in FEV 1 (control visit compared to baseline): mNGS pathogen positive versus negative exacerbation (qPCR targets), the number of normalized reads (log, cutoff of �5normalized reads) for the different target viruses (species level). No correlation was found between these markers and the different disease severity parameters (results not shown).

    Search related documents:
    Co phrase search for related documents
    • clinical severity and control visit: 1
    • clinical severity and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical severity and disease severity parameter: 1, 2, 3
    • clinical severity and exacerbation severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • clinical severity and mNGS pathogen: 1
    • clinical severity and negative exacerbation: 1
    • clinical severity and potential association: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • control visit and exacerbation severity: 1, 2
    • disease severity and exacerbation length: 1
    • disease severity and exacerbation severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • disease severity and follow marker: 1
    • disease severity and mNGS pathogen: 1, 2
    • disease severity and negative exacerbation: 1
    • disease severity and normalized read: 1, 2
    • disease severity and potential association: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • exacerbation length and normalized read: 1
    • exacerbation severity and negative exacerbation: 1
    • exacerbation severity and normalized read: 1, 2
    • exacerbation severity and potential association: 1, 2